CEO, FAST BioMedical
DO, MS, FACC, FCCP, FACOI
Chair, Heart Failure
Medical Advisory Board
CMO, SwanBio Therapeutics
DO, MS, FACC, FCCP, FACOI
With over 20 years of industry experience developing cardiovascular devices, Dr. Zelenkofske is currently Chief Medical Officer for SwanBio Therapeutics. He has led teams to regulatory approvals worldwide and led or participated in over a dozen NCE and sNDA approvals. Dr. Zelenkofske was previously CMO of Achillion Pharmaceuticals and Regado Biosciences and held senior leadership positions at Astra-Zeneca, Sanofi-Aventis, Boston Scientific and Novartis.
Vice President of Regulatory Affairs and CMC
Chief Financial Officer (acting)
Vice President of Product Development
Director of Clinical and Biomedical Projects